Zytiga Tablet 250 mg contains Abiraterone Acetate, an advanced hormonal therapy used in the treatment of prostate cancer. It is primarily prescribed for patients with metastatic castration-resistant prostate cancer (mCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC). Abiraterone Acetate works by reducing the production of androgens (male hormones) that stimulate the growth of prostate cancer cells.

Prostate cancer cells rely heavily on androgens such as testosterone for their growth and survival. Abiraterone Acetate inhibits an enzyme called CYP17 (17α-hydroxylase/C17,20-lyase), which plays a crucial role in the production of androgens in the testes, adrenal glands, and tumor tissues. By blocking this enzyme, Zytiga significantly reduces androgen levels in the body, thereby slowing or stopping the progression of prostate cancer.

Zytiga Tablet is typically used in combination with corticosteroids such as prednisone or prednisolone, which help manage certain side effects related to hormone suppression and maintain hormonal balance. This combination therapy has been shown to improve survival outcomes, reduce tumor progression, and enhance the quality of life for patients with advanced prostate cancer.

Zytiga Tablet 250 mg is usually prescribed as part of a comprehensive cancer treatment plan that may include hormone therapy, chemotherapy, or other targeted treatments depending on the stage and severity of the disease.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Zytiga Tablet 250 mg is indicated for:

• Metastatic castration-resistant prostate cancer (mCRPC)

• Metastatic hormone-sensitive prostate cancer (mHSPC)

• Advanced prostate cancer requiring androgen suppression therapy

Benefits of Zytiga Tablet

• Reduces androgen production that fuels prostate cancer growth

• Slows the progression of advanced prostate cancer

• Helps shrink or control tumor growth

• Improves survival outcomes in eligible patients

• Enhances overall quality of life during cancer treatment

Dosage and Administration

Zytiga Tablet should be taken strictly as prescribed by an oncologist or healthcare professional.

General recommendations may include:

• Typical dose: 1000 mg daily (usually four 250 mg tablets)

• Taken once daily on an empty stomach (at least 1 hour before or 2 hours after food)

• Usually administered together with prednisone or prednisolone as prescribed

Tablets should be swallowed whole with water and should not be crushed or chewed.

Precautions

• Inform your doctor if you have liver disease, heart disease, or high blood pressure.

• Regular monitoring of liver function, blood pressure, and potassium levels may be required during treatment.

• Not recommended for use in women or children.

• Women who are pregnant or may become pregnant should avoid handling crushed or broken tablets.

• Follow your doctor's instructions carefully to avoid complications.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Some patients may experience side effects, including:

• Fatigue or weakness

• High blood pressure

• Low potassium levels

• Joint pain or swelling

• Fluid retention or swelling in the legs

• Elevated liver enzymes

Serious side effects are rare but require immediate medical attention.

Storage Instructions

Store Zytiga Tablet 250 mg in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.